Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
PRCT Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
18.40%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-31.20%
PRCT Stock Analysis
PRCT
PE Ratio:
PRCT
PEG Ratio:
Not Available
PRCT
Forward EPS Growth (12 month):
0.00%
PRCT
PS Ratio:
4.7
PRCT
PSG Ratio:
0.2
PRCT
Forward Revenue Growth (12 month):
23.30%
PRCT Articles
No data was found